Morgan Stanley’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-623
| Closed | – | – | 6937 |
|
|
2018
Q2 | $0 | Buy |
623
+4
| +0.6% | – | ﹤0.01% | 6859 |
|
|
2018
Q1 | $0 | Sell |
619
-54
| -8% | -$8 | ﹤0.01% | 6817 |
|
|
2017
Q4 | $0 | Buy |
673
+54
| +9% | +$10 | ﹤0.01% | 6778 |
|
|
2017
Q3 | $0 | Hold |
619
| – | – | ﹤0.01% | 6693 |
|
|
2017
Q2 | $0 | Sell |
619
-59
| -9% | -$25 | ﹤0.01% | 6728 |
|
|
2017
Q1 | $0 | Sell |
678
-19
| -3% | -$11 | ﹤0.01% | 6671 |
|
|
2016
Q4 | $0 | Sell |
697
-107
| -13% | -$73 | ﹤0.01% | 6618 |
|
|
2016
Q3 | $1K | Hold |
804
| – | – | ﹤0.01% | 6466 |
|
|
2016
Q2 | $0 | Sell |
804
-191
| -19% | -$104 | ﹤0.01% | 6783 |
|
|
2016
Q1 | $0 | Sell |
995
-176
| -15% | -$119 | ﹤0.01% | 6841 |
|
|
2015
Q4 | $1K | Sell |
1,171
-61
| -5% | -$62 | ﹤0.01% | 6601 |
|
|
2015
Q3 | $1K | Sell |
1,232
-203
| -14% | -$184 | ﹤0.01% | 6560 |
|
|
2015
Q2 | $1K | Sell |
1,435
-166
| -10% | -$319 | ﹤0.01% | 6598 |
|
|
2015
Q1 | $3K | Buy |
1,601
+385
| +32% | +$516 | ﹤0.01% | 6409 |
|
|
2014
Q4 | $1K | Buy |
+1,216
| New | +$1.32K | ﹤0.01% | 6516 |
|
Morgan Stanley's BTX.WS Position: Q3 2018 in Review
Morgan Stanley sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 623 shares.
Morgan Stanley first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $3K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.
- Morgan Stanley reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
- Morgan Stanley sold 623 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
- Morgan Stanley first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
- Morgan Stanley's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $3K in Q1 2015.
- 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.